← Back to headlines
Palvella Therapeutics Price Target Raised by H.C. Wainwright
H.C. Wainwright has raised its price target for Palvella Therapeutics from $200 to $255.
25 Feb, 15:10 — 25 Feb, 15:10
ℹOnly 1 source covers this story
H.C. Wainwright has raised its price target for Palvella Therapeutics from $200 to $255.
